Metagenomics Market Growth, Trends, Key Opportunity and Value Chain 2019-2027 | Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies, Qiagen, Bio-Rad Laboratories, Inc.

According to a new market research study titled Metagenomics Market to 2027 – Global Analysis and Forecasts by Product, Application, and Geography. The global metagenomics market is expected to reach US$ 314.3 Mn in 2027 from US$ 165.8 in 2018.

The market is estimated to grow with a CAGR of 7.7% from 2018-2027. The growth of the market is driven by the factors such as increasing venture capital investments, advantages of metagenomics in biotechnology and industrial application of metagenomics likely to have a positive impact on the growth of the market in the coming years. However, high capital cost of metagenomics is anticipated to restrain the market growth.

Get Sample PDF of this Report @ https://www.theinsightpartners.com/sample/TIPRE00002997/

The major players operating in the metagenomics market include Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies, Qiagen, Bio-Rad Laboratories, Inc., Perkinelmer Inc., and Illumina Inc., f Hoffman-La Roche Ltd., Oxford Nanopore Technologies Ltd., Pacific Bioscience of California, Inc. among others. The market players are incorporating organic growth strategies such as introduction of new products into the market to sustain their global position in the highly competitive global metagenomics market. For instance, in August 2018, Agilent Technologies Inc. announced launch of the new version of its chromatography data system that will help to export lab files in the Allotrope Data Format (ADF), an emerging standard developed by a consortium of pharmaceutical companies.

Metagenomics can be defined as the study of the metagenome, which is collective genome of microorganisms. The microorganisms are collected from an environmental samples and the studies are conducted to provide information on the microbial diversity and ecology of a specific environment. The study of microorganism is conducted through the shotgun metagenomics technology/ technique which is used to extract the DNA from the environmental sample and sequence the small fragments. The metagenomic is the rising and vibrant field that has appropriated the tools used for standard genomics and applied for the study of the entire communities of microbes. This requires no need to isolate and culture the individual microbial species. The primary aim of the metagenomics is study and identify the genes and metabolic pathways present in the microbial species. The report would be of an interest to various stakeholders operating in the metagenomics market. These stakeholders include metagenomics manufacturers, vendors, and distributors, research institutes and government organizations, venture capitalists and other government funding organizations, research and consulting firms, healthcare institutions and others.

Ask For Discount @ https://www.theinsightpartners.com/discount/TIPRE00002997/

The objective of the study is to describe, define, and forecast the metagenomics market by type and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall market.

The extensive research for the microbial studies are being conducted to study the genetic make-up of the microorganisms. The collection of the microbial sample collected from the environmental resources owes the huge diversity in their genes. The study have helped to discover antibiotics and are expected to assist more in the drug discovery in the coming future. The current trend of the molecular-based approaches has enabled the field of the metagenomics to study the uncultured microorganisms. The metagenomics has also helped in the huge way for the clinical diagnostics and the clinical diagnostics is the current trend going on cross the world. Also the extensive research is been going-on currently for the environmental sectors.

Purchase this Report @ https://www.theinsightpartners.com/buy/TIPRE00002997/

Also the metagenomics have potential to discover products for the biotechnology, agriculture biotechnology, food technology and others. The potential of the metagenomics in the pharmaceuticals owe to the large hopes for growth opportunities for the market players. Also the novel innovations from the market players are likely to discover the solutions for the chronic infectious diseases. The initial cost of the primary set up for the metagenomics is very high, however, the technological advancement and the efforts by the market leader such as Illumina Inc., Pacific Bioscience of California Inc., among the others are likely to meet this challenge. These market players are aggressively working to provide cost effective solutions for the metagenomics studies. The healthcare industry is likely to experience the positive outcomes in the coming future.

The metagenomics based on application is segmented into clinical diagnostics, drug discovery, and others. Clinical Diagnostics segment is anticipated to grow at a CAGR of 7.2% during the forecast period. The metagenomics offers prodigious potential for the identification of uncultured microorganism that can be used to detect and diagnose infectious diseases and the genetic properties of the microorganism. Therefore, the segment held the largest market share among the application segment in the metagenomics market and is likely to dominate the market in coming forecast period.

Contact Us:

Call: +1-646-491-9876
Email: [email protected]